Related Experiment Video
Updated: Jun 13, 2026
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Stereotactic body radiation therapy for spinal metastases
Simon S Lo1, Arjun Sahgal, Jian Z Wang
1Department of Radiation Oncology, Arthur G. James Cancer Hospital, Ohio State University, Columbus, Ohio 43210, USA. Simon.Lo@osumc.edu
Discovery Medicine
|April 29, 2010
Summary
Stereotactic body radiation therapy (SBRT) offers effective pain and local control for spinal metastases. However, potential toxicities like myelopathy and fractures necessitate further clinical trials to define SBRT
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Stereotactic body radiation therapy (SBRT) is an evolving treatment for spinal metastases.
- Advances in radiation technology enable safe, effective delivery of ablative doses, including high-dose re-irradiation.
Purpose of the Study:
- To review the current practice of spine SBRT.
- To summarize the efficacy and toxicity of SBRT for spinal metastases.
Main Methods:
- Literature review of studies on SBRT for spinal metastases.
- Analysis of reported outcomes including pain relief, local control, and toxicity profiles.
Main Results:
- Published data indicate high rates of pain relief and local control with spine SBRT.
- Rare but serious toxicities, such as radiation-induced myelopathy and vertebral fractures, have been reported in a small patient subset.
Conclusions:
- Spine SBRT shows significant therapeutic potential for managing spinal metastases.
- Prospective trials are crucial to establish SBRT's role and optimal use in different clinical scenarios, balancing benefits against risks.
